Clinical Trial Update: Ketamine / Propofol Admixture "Ketofol" at Induction in the Critically Ill Against Etomidate: KEEP PACE Trial [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial comparing ketamine/propofol mix (ketofol) versus etomidate for induction in critically ill patients has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness

Drugs mentioned

• Etomidate (etomidate)
• Ketofol (ketamine/propofol admixture)

Snippet

Sponsor: Mayo Clinic | Conditions: Critical Illness | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-01-11